COMMUNIQUÉS West-GlobeNewswire

Onconetix, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q and Subsequent Filing

12/12/2024 - 23:00

Cincinnati, OH, Dec. 12, 2024 (GLOBE NEWSWIRE) -- Onconetix, Inc. (NASDAQ: ONCO) (the “Company”) announced that it received a letter from The Nasdaq Capital Market (“Nasdaq”) on December 6, 2024 indicating that the [...]

Extendicare Announces December 2024 Dividend of C$0.04 per Share

12/12/2024 - 23:00

MARKHAM, Ontario, Dec. 12, 2024 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has declared a cash dividend of C$0.04 per common share of the Company (the “Common [...]

Biomea Fusion Announces Oral and Poster Presentations of Icovamenib at the 22nd World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC)

12/12/2024 - 23:02

In preclinical experiments, icovamenib enhanced beta cell function and responsiveness of human islets to GLP-1-based therapies. These effects were associated with an increase in the expression levels of both the GLP-1 [...]

Cannara Biotech to Host Investor Webcast on Thursday December 19th, 2024

12/12/2024 - 15:30

MONTREAL, Dec. 12, 2024 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (“ Cannara ”, “the Company ”, “ us ” or “ we ”) ( TSXV: LOVE ) ( OTCQB: LOVFF ) ( FRA: 8CB0 ), a vertically integrated producer of premium-grade cannabis [...]

Invea Therapeutics Strengthens Leadership with Appointment of Dr. Stephen Doberstein, Veteran Biotech Executive, to Its Board of Directors

12/12/2024 - 16:05

Dr. Doberstein brings extensive biotech leadership experience as the company advances its AI-powered pipeline into Phase 2 for immune-mediated inflammatory disorders GUILFORD, Conn., Dec. 12, 2024 (GLOBE NEWSWIRE) -- [...]

ACARIZAX® approved in Europe for treatment of young children

12/12/2024 - 16:06

ALK ( ALKB:DC / OMX: ALK B ) today announced that its European regulatory filing for ACARIZAX ® (house dust mite sublingual allergy immunotherapy tablet) in young children aged five to 11 has been approved by the health [...]

Aptose Announces Publication of Preclinical Data in AACR Journal Demonstrating Tuspetinib’s Unique Mechanism of Action and Synthetic Lethality on AML Cells When Combined with Venetoclax

12/12/2024 - 16:15

Peer-reviewed publication details unique TUS mechanism of action TUS+VEN combination synthetic lethality overcomes resistance to VEN Tuspetinib prolongs survival in multiple AML models resistant to other drugs Findings [...]

EssilorLuxottica: Les objectifs à court terme de réduction des émissions de gaz à effet de serre d'EssilorLuxottica ont été validés par l’initiative Science Based Target (SBTi)

12/12/2024 - 18:00

Les objectifs à court terme de réduction des émissions de gaz à effet de serre d'EssilorLuxottica ont été validés par l’initiative Science Based Target (SBTi) Paris, France (12 décembre 2024) – EssilorLuxottica a [...]

EssilorLuxottica: EssilorLuxottica’s greenhouse gas emissions reduction targets validated by the Science Based Targets initiative (SBTi)

12/12/2024 - 18:00

EssilorLuxottica’s greenhouse gas emissions reduction targets validated by the Science Based Targets initiative (SBTi) Paris, France (12 December 2024) – EssilorLuxottica announced today that its near-term greenhouse [...]

Palisade Bio Announces Pricing of $5 Million Underwritten Public Offering Priced At-Market Under Nasdaq Rules

12/12/2024 - 18:05

Carlsbad, CA, Dec. 12, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc, (Nasdaq: PALI) (“Palisade,” “Palisade Bio” or the “Company”), a clinical-stage biopharmaceutical company focused on developing novel therapeutics for [...]

InspireMD Announces Expected Retirement of its CFO Craig Shore and CFO Transition in 2025

12/12/2024 - 13:00

MIAMI, Dec. 12, 2024 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) for the prevention of stroke, today announced that Craig Shore, Chief Financial [...]

Avextra Supports First Fully EU-Funded Psilocybin Therapy Study, Now Approved by EMA

12/12/2024 - 13:00

Exclusive Industry Role : Avextra is the industry partner in the first EU-funded project focused on psychedelic-assisted therapy for patients in palliative care suffering from depression, with a total grant of over 6.5 [...]

Tilray Alternative Beverages Unveils HERB & BLOOM: A Cutting-Edge Era of Hemp-Derived Delta-9 THC Beverages

12/12/2024 - 13:00

NEW YORK, Dec. 12, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), a leading global lifestyle and consumer packaged goods company, is pleased to present the official launch of Herb & Bloom , [...]

Elicio Therapeutics Presents Updated Results from ELI-002 Phase 1 AMPLIFY-201 Study at ESMO Immuno-Oncology Congress 2024

12/12/2024 - 13:00

Updated Phase 1 data include a 16.3-month median recurrence-free survival (“mRFS”) and 28.9-month median overall survival (“mOS”) from full study population Strong correlation observed between mRFS and strength of T [...]

Zentalis Pharmaceuticals Announces Key Management Appointments

12/12/2024 - 13:00

Wendy Chang appointed Chief People Officer; Haibo Wang appointed Chief Business Officer SAN DIEGO, Dec. 12, 2024 (GLOBE NEWSWIRE) -- Zentalis ® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical [...]

Dewpoint Therapeutics and ConcertAI Announce the First Phase of their Translational Oncology Partnership

12/12/2024 - 13:00

Supporting Dewpoint’s novel condensate modulating approach to drug previously ‘undruggable’ therapeutic targets, guided by ConcertAI’s Clinico-Genomic Solutions BOSTON and CAMBRIDGE, Mass., Dec. 12, 2024 (GLOBE NEWSWIRE [...]

Microbix Schedules Release of Results for Q4 Fiscal 2024

12/12/2024 - 13:00

Results Release and Webinar Discussion on Morning of December 19, 2024 MISSISSAUGA, Ontario, Dec. 12, 2024 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix ® ), a life sciences innovator, [...]

Fractyl Health Unveils Promising Preclinical Data Demonstrating Safety and Feasibility of Local Delivery of RJVA-001 Rejuva® Smart GLP-1™ Pancreatic Gene Therapy at the World Congress Insulin Resistance, Diabetes and Cardiovascular Disease (WCIRDC)

12/12/2024 - 13:00

RJVA-001 was successfully delivered in large animal Yucatan pig models at low total viral dose Results confirm ability to directly target pancreas with novel delivery catheter and route of administration Local delivery [...]

CervoMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

12/12/2024 - 13:00

BOSTON, Dec. 12, 2024 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO) (the “Company”), a clinical stage company focused on developing treatments for age-related neurologic disorders, today announced that it has granted [...]